1 of 1
Story summary
- A U.S. trial shows placental stem cells used during in utero surgery may improve spina bifida outcomes.
- Dr. Diana Farmer led the study and said therapy improved mobility and quality of life.
- The trial involved six unborn babies and showed safety, with no adverse effects.
- England and Wales involve about 536 spina bifida pregnancies annually.
